| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 9.472 | 7.712 | 13.982 | 3.505 | 63 | 0 | 40 | 0 | 0 | 0 |
| Total Income - EUR | 9.472 | 8.288 | 15.029 | 3.505 | 63 | 0 | 40 | 0 | 0 | 0 |
| Total Expenses - EUR | 9.534 | 9.417 | 12.070 | 5.020 | 1.653 | 435 | 134 | 274 | 0 | 90 |
| Gross Profit/Loss - EUR | -62 | -1.129 | 2.959 | -1.515 | -1.590 | -435 | -93 | -274 | 0 | -90 |
| Net Profit/Loss - EUR | -346 | -1.294 | 2.808 | -1.621 | -1.591 | -435 | -94 | -274 | 0 | -90 |
| Employees | 2 | 2 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Hightech Medical & Engineering Srl-D
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 2.034 | 1.057 | 2.609 | 592 | 589 | 577 | 19 | 9 | 9 | 0 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 522 | 497 | 827 | 587 | 576 | 565 | 0 | 0 | 0 | 0 |
| Cash | 1.512 | 560 | 1.782 | 5 | 14 | 13 | 19 | 9 | 9 | 0 |
| Shareholders Funds | -301 | -1.593 | 1.243 | -401 | -1.984 | -2.382 | -2.907 | -3.189 | -3.180 | -3.252 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 2.335 | 2.650 | 1.366 | 993 | 2.574 | 2.959 | 2.926 | 3.198 | 3.189 | 3.252 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4321 - 4321" | |||||||||
| CAEN Financial Year |
4321
|
|||||||||
Comments - Hightech Medical & Engineering Srl-D